brimonidine
Brimonidine is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.. Reference standards of Brimonidine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => Brimonidine for system suitability (Y0001634)
[catalogue_number] => PA EPY0001634
[category_ids] => ,150,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => NA
[pslug] => brimonidine-for-system-suitability-y0001634-paepy0001634
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Brimonidine for system suitability (Y0001634)
stdClass Object
(
[pname] => Brimonidine tartrate (Y0001658)
[catalogue_number] => PA EPY0001658
[category_ids] => ,150,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => NA
[pslug] => brimonidine-tartrate-y0001658-paepy0001658
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Brimonidine tartrate (Y0001658)